Home/News/Market context Source: Investing.com ↗ H.C. Wainwright reiterates Disc Medicine stock rating on trial data Published Sep 10, 2026 11:39 UTC | Translation unavailable. Please try again. Original report Read the original report on Investing.com ↗ Recommended marketsNo specific asset was identified in this report; browse live USDT reference pairs.Browse markets → USDC/USDT $1.00 -0.01% BTC/USDT $86,317.50 +1.13% ETH/USDT $2,747.52 +0.67% ZEC/USDT $1,627.09 +8.76% XRP/USDT $1.62 +6.57%